Atlas Trials

Xiujuan Qu

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Xiujuan Qu

RecordFirmDate
Trastuzumab in Combination With Serplulimab and Chemotherapy for the Treatment of HER2-overexpressing Unresectable Locally Advanced or Metastatic Biliary Tract Cancer or Urothelial Carcinoma After Failure of Standard Therapy (NCT07506057)Xiujuan Qu2025-07-15
Plasma Multi - Omics Detection for Evaluating Efficacy and Recurrence Risk in Oligometastatic Colorectal Cancer Conversion Therapy (NCT07492238)Xiujuan Qu2025-03-20

Track Xiujuan Qu automatically

Every clearance here is in the API, with alerts when new ones post.